| scholarly article | Q13442814 |
| P50 | author | José C Fernández-Checa | Q38544954 |
| Montserrat Marí | Q56872493 | ||
| Anna Moles | Q58992193 | ||
| P2093 | author name string | Núria Tarrats | |
| P2860 | cites work | Cathepsin D targeted by acid sphingomyelinase-derived ceramide | Q24529823 |
| History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells | Q28190388 | ||
| Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation | Q28240307 | ||
| Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis | Q28263747 | ||
| Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells | Q28295485 | ||
| Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus | Q28613227 | ||
| Liver fibrosis | Q29547449 | ||
| Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver | Q29616840 | ||
| Cathepsin D in cancer metastasis: a protease and a ligand | Q33586471 | ||
| Unraveling the role of proteases in cancer | Q33838143 | ||
| Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis | Q34320916 | ||
| Cathepsin L is required for endothelial progenitor cell-induced neovascularization | Q34387265 | ||
| Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c | Q34457741 | ||
| The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity | Q34512981 | ||
| Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis | Q35595788 | ||
| Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ | Q35649446 | ||
| Extracellular proteases as targets for treatment of cancer metastases | Q35881244 | ||
| Lysosomes as targets for cancer therapy | Q36099892 | ||
| Mechanisms of liver fibrosis | Q36247948 | ||
| Catalytically inactive human cathepsin D triggers fibroblast invasive growth | Q36321336 | ||
| Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation | Q36509878 | ||
| Hepatic stellate cells and the reversal of fibrosis | Q36588244 | ||
| Cysteine cathepsins: multifunctional enzymes in cancer | Q36600996 | ||
| Processing of human cathepsin D is independent of its catalytic function and auto-activation: involvement of cathepsins L and B. | Q36646524 | ||
| Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. | Q38333252 | ||
| Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta ) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. | Q38358348 | ||
| Elucidating the function of secreted maspin: inhibiting cathepsin D-mediated matrix degradation | Q38533885 | ||
| Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis | Q39785797 | ||
| Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line | Q40910869 | ||
| Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates | Q42119374 | ||
| Increased activities of liver cathepsins T and D in carbon tetrachloride-treated rats | Q42250707 | ||
| Regulation of cell growth by redox-mediated extracellular proteolysis of platelet-derived growth factor receptor beta | Q43603110 | ||
| Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice. | Q43744841 | ||
| Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer | Q44068250 | ||
| Pepstatin A attenuates the inhibitory effect of N-acetyl-L-cysteine on proliferation of hepatic myofibroblasts (stellate cells). | Q44145455 | ||
| Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice | Q44391043 | ||
| Cysteine cathepsins (proteases)--on the main stage of cancer? | Q44897180 | ||
| Histone h3 modifications in rat hepatic stellate cells by ethanol | Q46531252 | ||
| Contact of high-invasive, but not low-invasive, melanoma cells to native collagen I induces the release of mature cathepsin B. | Q46870610 | ||
| Lysosomal Cathepsins B and L and Stef in A Blood Levels in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis: Potential Clinical Implications | Q60245921 | ||
| Kinetics of in vivo inhibition of tissue cathepsin D by pepstatin A | Q67979755 | ||
| Collagenolytic cathepsin B and L activity in experimental fibrotic liver and human liver | Q68036770 | ||
| Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro | Q68265043 | ||
| Cathepsin D serum mass concentrations in patients with hepatocellular carcinoma and/or liver cirrhosis | Q71669546 | ||
| Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair | Q73285228 | ||
| Proteome analysis of rat hepatic stellate cells | Q74071343 | ||
| Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic | Q74292004 | ||
| Regulation of hepatic stellate cell activation and growth by transcription factor myocyte enhancer factor 2 | Q80853276 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1297-1307 | |
| P577 | publication date | 2009-04-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential | |
| P478 | volume | 49 |
| Q36948156 | A Comparative Study of Cathepsin D Expression in Peripheral and Central Giant Cell Granuloma of the Jaws by Immunohistochemistry Technique |
| Q30391185 | A Fluorescence-Guided Laser Ablation System for Removal of Residual Cancer in a Mouse Model of Soft Tissue Sarcoma. |
| Q34182447 | A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis |
| Q41921041 | ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis |
| Q34086900 | Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis |
| Q34990566 | Angiogenin secretion from hepatoma cells activates hepatic stellate cells to amplify a self-sustained cycle promoting liver cancer |
| Q24611183 | Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment |
| Q95334090 | Cathepsin B deficiency ameliorates liver lipid deposition, inflammatory cell infiltration, and fibrosis after diet-induced nonalcoholic steatohepatitis |
| Q41353599 | Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-α/ASK1/JNK pathway |
| Q35668715 | Cathepsin B overexpression due to acid sphingomyelinase ablation promotes liver fibrosis in Niemann-Pick disease |
| Q33920338 | Cathepsin L and B as Potential Markers for Liver Fibrosis: Insights From Patients and Experimental Models. |
| Q92208473 | Cathepsin S regulates renal fibrosis in mouse models of mild and severe hydronephrosis |
| Q37187482 | Cathepsin S-mediated fibroblast trans-differentiation contributes to left ventricular remodelling after myocardial infarction |
| Q39552232 | Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis |
| Q37603340 | Cysteine cathepsins control hepatic NF-κB-dependent inflammation via sirtuin-1 regulation. |
| Q33744692 | Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice |
| Q55117842 | Differential Role of Cathepsins S and B In Hepatic APC-Mediated NKT Cell Activation and Cytokine Secretion. |
| Q92846993 | Differential Roles of Cysteinyl Cathepsins in TGF-β Signaling and Tissue Fibrosis |
| Q44941860 | Enhanced activity of lysosomal proteases in activated rat hepatic stellate cells is associated with a concomitant increase in the number of the mannose-6-phosphate/insulin-like growth factor II receptor |
| Q55114038 | Epithelial cell-derived cytokines CST3 and GDF15 as potential therapeutics for pulmonary fibrosis. |
| Q36076151 | Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity |
| Q98164841 | GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition |
| Q38944998 | Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development |
| Q63915894 | Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in Sprague–Dawley Rats † |
| Q36528166 | Inhibition of lysosomal protease cathepsin D reduces renal fibrosis in murine chronic kidney disease. |
| Q37621079 | Loss of lysosomal membrane protein NCU-G1 in mice results in spontaneous liver fibrosis with accumulation of lipofuscin and iron in Kupffer cells |
| Q38195943 | Lysosomal cholesterol accumulation: driver on the road to inflammation during atherosclerosis and non-alcoholic steatohepatitis |
| Q37257361 | Mechanisms of fibrosis in acute liver failure |
| Q38277840 | Mitochondrial cholesterol accumulation in alcoholic liver disease: Role of ASMase and endoplasmic reticulum stress. |
| Q34392691 | Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe. |
| Q38773619 | New role and molecular mechanism of Gadd45a in hepatic fibrosis |
| Q92481927 | Prognostic and therapeutic relevance of cathepsin B in pediatric acute myeloid leukemia |
| Q61798628 | Quantitative proteomic characterization of lung tissue in idiopathic pulmonary fibrosis |
| Q33718504 | Regulation of TGF-β1-driven differentiation of human lung fibroblasts: emerging roles of cathepsin B and cystatin C. |
| Q33641523 | Retracted: Co-Depletion of Cathepsin B and uPAR Induces G0/G1 Arrest in Glioma via FOXO3a Mediated p27Kip1 Upregulation |
| Q50533517 | Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts |
| Q39167934 | Side population in LX2 cells decreased by transforming growth factor-β. |
| Q91792353 | The Role of Cathepsin B in Peritoneal Fibrosis due to Peritoneal Dialysis |
| Q38618873 | The Role of Ceramide in the Pathogenesis of Alcoholic Liver Disease |
| Q90448217 | The impact of Lactobacillus acidophilus on hepatic and colonic fibrosis induced by ethephon in a rat model |
| Q37800217 | The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. |
| Q42181812 | Treatment with CA-074Me, a Cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model of polymyositis |
| Q35197926 | Urinary candidate biomarker discovery in a rat unilateral ureteral obstruction model. |
| Q89682842 | Utilizing Experimental Mouse Model to Identify Effectors of Hepatocellular Carcinoma Induced by HBx Antigen |
| Q101476490 | c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis |
Search more.